Podcasts

In this podcast, Alfred Kim, MD, PhD, talks about the knowledge gaps that still exist about the COVID-19 vaccine for patients who are immunosuppressed.

In this podcast, Isabelle Amigues, MD, explains the reasoning behind why she and other rheumatologists suggest that practitioners stop using the term “connective tissue disease-associated interstitial lung disease.”

In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how it may influence your practice.

He talks about the challenges of treating progressive psoriatic arthritis, why certain patients progress to more severe disease, and how to change medication when needed.

He discusses some of the difficulties rheumatologists encounter when diagnosing psoriatic arthritis, and key indicators of the disease.

In this podcast, Mariana Kaplan, MD, and Sarthak Gupta, MD, discuss their findings on how sex differences in neutrophil functions may help in the understanding of differences seen in autoimmunity.

A recent study reviewed treatment options and tools available for addressing pain in patients with hidradenitis suppurativa. In this podcast, Lauren Orenstein, MD, discussed pharmacological and nonpharmacological options for patients with HS-related pain, as well as areas of future research needed to improve pain management for these patients.

In this podcast, Sarthak Gupta, MD, talks about about the diagnosis and management of ICI-induced inflammatory arthritis and why a multidisciplinary approach to the disease is key. 

Dr Lacy, professor of medicine at Mayo Clinic Jacksonville, discusses the causes and treatment of abdominal distention and bloating.

In this podcast, Jonathan Stine, MD, from the the Milton S. Hershey Medical Center of Pennsylvania State University, discusses his proof-of-concept study on the effects of exercise on gut dysbiosis and fatty liver disease.